Full-Year Net Income Up 8%; Full-Year Diluted EPS of
Company Returns
Fiscal Year Financial Highlights (12 months ended
- Full fiscal year revenue of
$23.3 million , up 3% year-over-year. - Operating expense decreased 6% to
$15.4 million . - Operating income increased 26% to
$7.8 million . - GAAP net income increased 8% to
$7.6 million . - Net income to common shareholders was
$7.4 million , up 12.0%. - EPS of
$0.41 per basic and$0.39 per diluted share. - The Company finished the period with
$27.3 million in cash and no bank debt. - The Company generated
$8.2 million in cash from operations for fiscal 2026. - During the fiscal year, the Company redeemed 175,233 preferred shares for the stated redemption price of
$10.70 per share for a total of$1,874,993 . - During the fiscal year, the Company repurchased and cancelled 143,904 common shares for an average price of
$12.50 per share for a total of$1,798,537 .
Fourth Fiscal Quarter Financial Highlights (three months ended
- Fourth quarter total revenue of
$5.6 million , down 3% year-over-year. - Operating expense decreased 11% to
$3.7 million . - Operating income increased 19% to
$1.9 million . - GAAP net income increased 16% to
$2.1 million . - Net income to common shareholders was
$2.1 million , up 16%. - EPS of
$0.11 per basic and diluted share. - On
June 18, 2026 , the Board declared a quarterly dividend of$0.02 per quarter ($0.08 per share annually) to shareholders of record onJune 30, 2026 . The cash dividends were paid to shareholders of record on or aboutAugust 14, 2026 . Subsequent dividends will be paid within 45 days of each fiscal quarter end.
“Simultaneously, we continue to expand our leadership position in traceability,” continued
“Our fiscal 2026 results demonstrate the operating leverage in our business model,” concluded
Fourth Fiscal Quarter Financial Results (three months ended
Revenue was
Fiscal Year Financial Results (12 months ended
Revenue increased 3% to
Return of Capital:
During the fiscal year, the Company redeemed 175,233 preferred shares at the stated redemption price of
During the fiscal year, the Company repurchased 143,904 common shares for a total of
On
Balance Sheet:
The Company had
Conference Call:
The Company will host a conference call at
Participant Dial-In Numbers:
Date:
Time:
Toll-Free: 1-877-407-9716
Toll/International 1-201-493-6779
Conference ID: 13762421
Replay Dial-In Numbers:
Toll Free: 1-844-512-2921
Toll/International: 1-412-317-6671
Conference ID: 13760307
Replay Start:
Replay Expiry:
About ReposiTrak
ReposiTrak, Inc. (NYSE: TRAK) is an AI-powered, integrated platform that connects retailers, wholesalers, suppliers, and food manufacturers through a suite of applications designed to reduce risk, support regulatory compliance, strengthen operational controls, and protect brand integrity. The ReposiTrak platform serves as a shared system of record across its solution areas, maintaining and synchronizing complex supplier and customer data to enable secure, accurate, and scalable information exchange.
ReposiTrak’s solutions are organized into three core product families: traceability, compliance and risk management, and supply chain solutions. Through its scalable, cloud-based platform and U.S.-based team of experts, the Company helps organizations streamline operations, improve data transparency, and meet evolving regulatory requirements across the food supply chain. For more information, visit www.repositrak.com.
Forward-Looking Statement
Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,” “project,” “predict,” “if”, “should” and “will” and similar expressions as they relate to ReposiTrak Inc., (“ReposiTrak”) are intended to identify such forward-looking statements. ReposiTrak may from time-to-time update these publicly announced projections, but it is not obligated to do so. Any projections of future results of operations should not be construed in any manner as a guarantee that such results will in fact occur. These projections are subject to change and could differ materially from final reported results. For a discussion of such risks and uncertainties, see “Risk Factors” in ReposiTrak annual report on Form 10-K, its quarterly report on Form 10-Q, and its other reports filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.
Consolidated Balance Sheets | ||||||||
|
|
| ||||||
|
| 2026 |
| 2025 | ||||
Assets |
|
|
|
|
|
| ||
Current Assets |
|
|
|
|
|
| ||
Cash |
| $ | 27,256,008 |
|
| $ | 28,568,805 |
|
Receivables, net of allowance for doubtful accounts of |
|
| 4,613,739 |
|
|
| 4,133,026 |
|
Contract asset – unbilled current portion |
|
| 433,783 |
|
|
| 428,585 |
|
Prepaid expense and other current assets |
|
| 449,298 |
|
|
| 555,384 |
|
Total Current Assets |
|
| 32,752,828 |
|
|
| 33,685,800 |
|
|
|
|
|
|
|
| ||
Property and equipment, net |
|
| 303,896 |
|
|
| 602,172 |
|
|
|
|
|
|
|
| ||
Other Assets: |
|
|
|
|
|
| ||
Note receivable, net |
|
| 2,277,778 |
|
|
| - |
|
Investment in equity securities, at fair value |
|
| 3,462,700 |
|
|
| - |
|
Deposits and other assets |
|
| 122,414 |
|
|
| 22,414 |
|
Prepaid expense – less current portion |
|
| 2,762 |
|
|
| 6,568 |
|
|
| 20,883,886 |
|
|
| 20,883,886 |
| |
Deferred income taxes |
|
| 51,035 |
|
|
| - |
|
Capitalized software costs, net |
|
| - |
|
|
| 128,207 |
|
Capitalized software development in progress |
|
| 1,000,412 |
|
|
| - |
|
Total Other Assets |
|
| 27,800,987 |
|
|
| 21,041,075 |
|
|
|
|
|
|
|
| ||
Total Assets |
| $ | 60,857,711 |
|
| $ | 55,329,047 |
|
|
|
|
|
|
|
| ||
Liabilities and Shareholders’ Equity |
|
|
|
|
|
| ||
Current liabilities |
|
|
|
|
|
| ||
Accounts payable |
| $ | 522,404 |
|
| $ | 282,146 |
|
Accrued liabilities |
|
| 3,240,318 |
|
|
| 1,841,839 |
|
Contract liability – deferred revenue |
|
| 4,509,815 |
|
|
| 3,175,908 |
|
Notes payable and financing leases – current |
|
| 232,842 |
|
|
| 231,225 |
|
Total current liabilities |
|
| 8,505,379 |
|
|
| 5,531,118 |
|
|
|
|
|
|
|
| ||
Long-term liabilities |
|
|
|
|
|
| ||
Notes payable and financing leases – less current portion |
|
| 61,498 |
|
|
| 278,748 |
|
Total liabilities |
|
| 8,566,877 |
|
|
| 5,809,866 |
|
|
|
|
|
|
|
| ||
Commitments and contingencies |
|
|
|
|
|
| ||
|
|
|
|
|
|
| ||
Stockholders’ equity: |
|
|
|
|
|
| ||
Preferred Stock; |
|
|
|
|
|
| ||
Series B Preferred, 700,000 shares authorized; 160,865 and 336,098 shares issued and outstanding at |
|
| 1,609 |
|
|
| 3,361 |
|
Common Stock, |
|
| 181,896 |
|
|
| 182,830 |
|
Additional paid-in capital |
|
| 59,159,098 |
|
|
| 62,181,156 |
|
Accumulated other comprehensive loss |
|
| (36,708 | ) |
|
| (11,256 | ) |
Accumulated deficit |
|
| (7,015,061 | ) |
|
| (12,836,910 | ) |
Total stockholders’ equity |
|
| 52,290,834 |
|
|
| 49,519,181 |
|
Total liabilities and stockholders’ equity |
| $ | 60,857,711 |
|
| $ | 55,329,047 |
|
Consolidated Statements of Operations | ||||||||
|
| For the Years Ended | ||||||
|
| |||||||
|
| 2026 |
| 2025 | ||||
|
|
|
|
|
|
| ||
Revenue |
| $ | 23,287,319 |
|
| $ | 22,606,066 |
|
|
|
|
|
|
|
| ||
Operating expense: |
|
|
|
|
|
| ||
Cost of revenue and product support |
|
| 3,306,855 |
|
|
| 3,681,330 |
|
Sales and marketing |
|
| 5,751,151 |
|
|
| 5,843,272 |
|
General and administrative |
|
| 5,738,314 |
|
|
| 5,602,807 |
|
Depreciation and amortization |
|
| 647,637 |
|
|
| 1,251,514 |
|
Total operating expense |
|
| 15,443,957 |
|
|
| 16,378,923 |
|
|
|
|
|
|
|
| ||
Income from operations |
|
| 7,843,362 |
|
|
| 6,227,143 |
|
|
|
|
|
|
|
| ||
Other income (expense): |
|
|
|
|
|
| ||
Interest income |
|
| 1,541,459 |
|
|
| 1,383,535 |
|
Interest expense |
|
| (38,483 | ) |
|
| (48,671 | ) |
Gain on lease termination |
|
| - |
|
|
| 12,262 |
|
Realized gain (loss) on short term investments |
|
| (19,052 | ) |
|
| 97,384 |
|
Unrealized gain (loss) on short term investments |
|
| 192,200 |
|
|
| (17,676 | ) |
Income before income taxes |
|
| 9,519,486 |
|
|
| 7,653,977 |
|
|
|
|
|
|
|
| ||
(Provision) for income taxes |
|
| (1,949,999 | ) |
|
| (675,850 | ) |
Net income |
|
| 7,569,487 |
|
|
| 6,978,127 |
|
|
|
|
|
|
|
| ||
Dividends on Preferred Stock |
|
| (167,804 | ) |
|
| (360,306 | ) |
|
|
|
|
|
|
| ||
Net income applicable to common shareholders |
| $ | 7,401,683 |
|
| $ | 6,617,821 |
|
|
|
|
|
|
|
| ||
Weighted average shares, basic |
|
| 18,236,000 |
|
|
| 18,262,000 |
|
Weighted average shares, diluted |
|
| 18,981,000 |
|
|
| 19,141,000 |
|
Basic earnings per share |
| $ | 0.41 |
|
| $ | 0.36 |
|
Diluted earnings per share |
| $ | 0.39 |
|
| $ | 0.35 |
|
|
|
|
|
|
|
| ||
Comprehensive income: |
|
|
|
|
|
| ||
Net income |
| $ | 7,569,487 |
|
| $ | 6,978,127 |
|
Other comprehensive loss: |
|
|
|
|
|
| ||
Unrealized gain (loss) on available-for-sale securities |
|
| (25,452 | ) |
|
| 16,134 |
|
Total comprehensive income |
| $ | 7,544,035 |
|
| $ | 6,994,261 |
|
Consolidated Statements of Cash Flows | ||||||||
|
| For the Years Ended | ||||||
|
| |||||||
|
| 2026 |
| 2025 | ||||
Cash flows from operating activities: |
|
|
|
|
|
| ||
Net income |
| $ | 7,569,487 |
|
| $ | 6,978,127 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
| ||
Depreciation and amortization |
|
| 647,637 |
|
|
| 1,251,514 |
|
Amortization of operating right of use asset |
|
| - |
|
|
| 63,597 |
|
Amortization of loan discount |
|
| (77,778 | ) |
|
| - |
|
Stock compensation expense |
|
| 444,510 |
|
|
| 403,783 |
|
Gain on termination of operating lease |
|
| - |
|
|
| (12,262 | ) |
Unrealized gain (loss) on investments |
|
| (192,200 | ) |
|
| 17,676 |
|
Net amortization/accretion |
|
| (81,235 | ) |
|
| - |
|
Realized loss on investments |
|
| 19,052 |
|
|
| (97,384 | ) |
Common stock received in settlement of accounts receivable |
|
| (2,325,000 | ) |
|
| - |
|
Deferred income tax benefit |
|
| (51,035 | ) |
|
| - |
|
Bad debt expense |
|
| 950,000 |
|
|
| 600,000 |
|
(Increase) decrease in: |
|
|
|
|
|
| ||
Accounts receivables |
|
| (1,744,042 | ) |
|
| (1,221,596 | ) |
Operating right of use asset |
|
| - |
|
|
| 186,709 |
|
Contract assets and unbilled receivables |
|
| (5,197 | ) |
|
| - |
|
Long-term receivables, prepaids and other assets |
|
| 109,892 |
|
|
| (447,479 | ) |
Increase (decrease) in: |
|
|
|
|
|
| ||
Accounts payable |
|
| 240,258 |
|
|
| 17,060 |
|
Operating lease liability |
|
| - |
|
|
| (250,786 | ) |
Accrued liabilities |
|
| 1,386,550 |
|
|
| 196,499 |
|
Deferred revenue |
|
| 1,333,907 |
|
|
| 734,674 |
|
Net cash provided by operating activities |
|
| 8,224,806 |
|
|
| 8,420,132 |
|
|
|
|
|
|
|
| ||
Cash flows from investing activities: |
|
|
|
|
|
| ||
Issuance of note receivable |
|
| (3,000,000 | ) |
|
| - |
|
Purchase of property and equipment |
|
| (16,594 | ) |
|
| (15,965 | ) |
Investment deposit |
|
| (100,000 | ) |
|
| - |
|
Capitalization of software development costs in progress |
|
| (1,000,412 | ) |
|
| - |
|
Sale (purchase) of marketable securities |
|
| - |
|
|
| 16,134 |
|
Net cash (used in) provided by investing activities |
|
| (4,117,006 | ) |
|
| 169 |
|
|
|
|
|
|
|
| ||
Cash flows from financing activities: |
|
|
|
|
|
| ||
Common stock buyback/retirement |
|
| (1,798,537 | ) |
|
| (200,035 | ) |
Redemption of Series B Preferred |
|
| (1,874,993 | ) |
|
| (2,999,970 | ) |
Proceeds from exercise of warrants |
|
| - |
|
|
| 79,120 |
|
Proceeds from employee stock plan |
|
| 104,519 |
|
|
| 134,346 |
|
Dividends paid |
|
| (1,635,953 | ) |
|
| (1,656,377 | ) |
Payments on notes payable and capital leases |
|
| (215,633 | ) |
|
| (362,442 | ) |
Net cash used in financing activities |
|
| (5,420,597 | ) |
|
| (5,005,358 | ) |
|
|
|
|
|
|
| ||
Net (decrease) increase in cash and cash equivalents |
|
| (1,312,797 | ) |
|
| 3,414,943 |
|
|
|
|
|
|
|
| ||
Cash and cash equivalents at beginning of period |
|
| 28,568,805 |
|
|
| 25,153,862 |
|
Cash and cash equivalents at end of period |
| $ | 27,256,008 |
|
| $ | 28,568,805 |
|
|
|
|
|
|
|
| ||
Supplemental Disclosure of Cash Flow Information |
|
|
|
|
|
| ||
Cash paid for income taxes |
| $ | 734,928 |
|
| $ | 435,059 |
|
Cash paid for interest |
| $ | 15,411 |
|
| $ | 21,023 |
|
Cash paid for operating leases |
| $ | - |
|
| $ | 56,244 |
|
|
|
|
|
|
|
| ||
Supplemental Disclosure of Non-Cash Investing and Financing Activities |
|
|
|
|
|
| ||
Common Stock to pay accrued liabilities |
| $ | 421,604 |
|
| $ | 313,218 |
|
Dividends accrued on Preferred Stock |
| $ | 167,804 |
|
| $ | 360,306 |
|
Right of use asset |
| $ | - |
|
| $ | 654,444 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20260928265480/en/
Investor Relations Contact:
Investor-relations@repositrak.com
Or
FNK IR
646.809.4048
rob@fnkir.com
Source: ReposiTrak